Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · Real-Time Price · USD

14.87

+0.91 (6.52%)

At close: Aug 10, 2026, 4:00 PM EDT

14.79

-0.08 (-0.54%)

Pre-market: Aug 11, 2026, 4:55 AM EDT

Summit Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-856.09	-1,080	-221.32	-614.93	-78.78	-88.6
Depreciation & Amortization	0.17	0.15	0.09	0.2	1.26	2.46
Stock-Based Compensation	384.04	732.42	50.98	14.11	11.95	12.8
Other Adjustments	-9.84	-7.33	12.66	524.38	14.12	0.82
Change in Receivables	-	-	-	0.36	0.98	-1.14
Changes in Accounts Payable	-0.09	15.3	2.02	2.26	-4.13	-1.71
Changes in Accrued Expenses	42.27	15.84	18.44	-2.61	6.39	8.23
Changes in Unearned Revenue	-	-	-	-	-7.28	-0.81
Changes in Other Operating Activities	-20.02	0.27	-4.97	-0.53	13.91	-4.63
Operating Cash Flow	-458.43	-322.93	-142.11	-76.76	-41.58	-72.59
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-1.39	-0.66	-0.14	-0.13	-0.62	-0.31
Sale of Property, Plant & Equipment	-	-	-	0.23	-	-
Purchases of Investments	-887.27	-484.99	-680.03	-321.02	-	-
Proceeds from Sale of Investments	626.09	311.34	489.84	208.17	-	-
Cash Acquisitions	-	-	-15.01	-475.02	-	-
Investing Cash Flow	-262.57	-174.31	-205.34	-587.77	-0.62	-0.31
Long-Term Debt Issued	-	-	-	-	545	110
Long-Term Debt Repaid	-	-	-100	-24.69	-25	-110
Net Long-Term Debt Issued (Repaid)	-	-	-100	-24.69	520	0
Issuance of Common Stock	342.47	617.53	481.23	111.82	100.4	78.09
Net Common Stock Issued (Repurchased)	342.47	617.53	481.23	111.82	100.4	78.09
Other Financing Activities	-	-	-	-0.62	-0.16	-0.17
Financing Cash Flow	842.51	617.53	381.23	86.51	620.24	77.92
Foreign Exchange Rate Adjustments	-0.02	0.1	-0.02	0.84	-1.22	0.35
Net Cash Flow	121.49	120.4	33.76	-577.18	576.82	5.37
Free Cash Flow	-459.82	-323.59	-142.25	-76.89	-42.21	-72.89
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.60	-0.43	-0.20	-0.12	-0.22	-0.55
Levered Free Cash Flow	-835.15	-1,049	-305.89	-640.42	450.75	-85.38
Unlevered Free Cash Flow	895.79	1,125	211.41	-432.99	-62.56	-82.97

SEC Filings: 10-K · 10-Q